|
April. 16, 2019 |
|
|
July. 11, 2025 |
|
|
jRCTs051190006 |
Prospective Evaluation of the Molecular Effects of Itraconazole as an anti-cancer agent: A Window of Opportunity Study (Window trial) |
|
Window trial (Window trial) |
Tsubamoto Hiroshi |
||
Hyogo Medical University Hospital |
||
Mukogawa 1-1, Nishinomiya, Hyogo |
||
+81-798-45-6481 |
||
tsuba@hyo-med.ac.jp |
||
Tsubamoto Hiroshi |
||
Hyogo Medical University Hospital |
||
Mukogawa 1-1, Nishinomiya, Hyogo |
||
+81-798-45-6481 |
||
tsuba@hyo-med.ac.jp |
Suspended |
Aug. 10, 2015 |
||
| Sept. 24, 2015 | ||
| 200 | ||
Interventional |
||
single arm study |
||
double blind |
||
no treatment control/standard of care control |
||
single assignment |
||
treatment purpose |
||
Patients who have window period before standard treatment |
||
Patients who have drugs which interferes CYP3A |
||
| 20age old over | ||
| No limit | ||
Both |
||
Solid tumor |
||
Administration of itraconazole for 2~4 weeks |
||
Repurposing, window trial |
||
drug repositioning |
||
D009369 |
||
D058492 |
||
Ki-67 index, serological and/or radiological response |
||
Symptom control ratio, Response rate |
||
| Kobe city hospital organization certified review board | |
| 2-1-1, Minatojima-minamimachi Chuo-ku, Kobe-city, Hyogo | |
+81-78-302-5176 |
|
| c_crb@kcho.jp | |
| Approval | |
Mar. 15, 2019 |
| UMIN000018388 | |
| University Hospital Medical Information Network |
none |